PharmaCircle is the only information service provider that integrates complete drug delivery (DD) information into the broader analysis of the products/pipeline and deals of companies within the Pharmaceutical and Biotechnology fields. PharmaCircle covers 5100+ pharmaceutical, biotechnology, specialty pharma, drug delivery, generic, pharmaceutical service and venture capital companies, 19000+ pipeline & marketed products (17,000+ active), 4900 molecules and 1050+ molecule mechanisms, 34000+ DD deals, acquisitions and news, 5000+ product sales/royalty/manufacturing and licensing revenues. The updating of data and information happens within the same day or two after the information becomes publicly available. More specifically, PharmaCircle's Web based content includes;

Company Profiles Contact/address, year founded, business model, capabilities, facility & manufacturing locations, therapeutic and DD categories of focus, partners (product/technology), history/dates of acquisitions, financials, chart of pipeline/products by phase, separated as DD and non-DD and a table for DD technologies if any as well as a table of pipeline and products sorted by phase, route and indications.(see Profile for Genentech; 1,2,3,4&5)
Products/pipeline (research to marketed phase) info includes indications, phase, partnerships/territories, US/EU/JAP labels, orphan drug status, administration route (injectable, o ral, transdermal, inhalation and other 180+ categories), specific DD technology used, frequency of administration, excipients used, color, shape, dose, approval year, patent exclusivity , etc. All relevant FDA information is integrated to the product info with hyperlinks (market/patent exclusivity info, approval dates/history, therapeutic equivalents, packaging info, etc.) (see FDA info). Historical news as well as a summary of the clinical development results from news releases are summarized with hyperlink to references. (see Oral-lyn 1,2,3). Product sales. royalty, licensing and manufacturing revenues are extracted from the financial documents and displayed in a table and graph as a function of year, DD and therapeutic categories. Products competing in the same indication and mechanism is provided in a customizable table.
Molecule specific information, such as molecule type, mechanism, structure, m olecular weight, water solubility, pKa, logP, charge, chirality, bitterness, t1/2, Vd, Cl, bioavailability, first pass effect, pGP effect, etc. with references (see Fentanyl). Our powerful search engine filters thousands of molecules by any of the above molecule properties to identify potential product candidates (see an example search).
FDA Product information and a powerful search engine that puts market/Orange Book patent exclusivity, approval dates/history, therapeutic equivalents, labels, packaging, route & dosage form type info at your fingertips (see FDA info).
Pharma/Biotech deals (technology/product), product, technology and company acquisitions categorized by therapeutic category, phase, financial details (deal value, royalty, milestones etc.).(see deals)
Products sales values for the World, US, EX-US, Europe and Japan are provided from 1996 to 2008 for >750 products when available in the financial statements organized by DD as well as therapeutic category (1,2, 3). Royalty and licensing vales are also provided for partnered programs along with royalty calculations
Nearly 400 VC Companies and their DD and Biotech/Pharma investments charted by business model, DD and therapeutic category
Extensive charts for data with 2-D and 3-D charting capabilities
Extensive search forms for technologies, companies (see 1&2), pipeline and products (see 1&2), deals&news (see 1), The search results are also provided in Excel sheets and Word documents.